New hires and promotions in the biopharma industry, including: Dunad, Foghorn, Indaptus, Medicenna, Processa, Vigil.

Med-tech firms raising money in public or private financings, including: Figur8.

New hires and promotions in the med-tech industry, including: Biophotas, Haemonetics, Heartbeam, Lumabridge, Nyra, Zerigo.

Med-tech happenings, including deals and partnerships, grants, preclinical data and other news in brief: Agilent Technologies, Corstrata, Dariohealth, Element Biosciences, Fesarius Therapeutics, Health Recovery Solutions.

Regulatory snapshots, including global submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Pentax Medical, Qiagen.

The top 10 med-tech stock gainers and losers for the week.

Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Astrazeneca, Basilea, Mesoblast, Sanofi.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Affimed, Altrubio, Amgen, Cullinan, Eli Lilly, Neurobo, Theracosbio.

Biopharmas raising money in public or private financings, including: Adamis, Collegium, Cybin, Gracell, IO, Orgenics.

New hires and promotions in the biopharma industry, including: Ankyra, Arbor, Avalyn, Oncopeptides, Serimmune, Viracta, Vivoryon, Voyager, Xortx.